Skip to content
Application 209964
- Type
- NDA
- Sponsor
- AMGEN INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | CORLANOR | IVABRADINE | SOLUTION;ORAL | 5MG/5ML (1MG/ML) | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 55513-813 | Corlanor | ivabradine | Amgen Inc | NDA | Current |
| 55513-813 | Corlanor | ivabradine | Amgen Inc | NDA | Current |
| 55513-813 | Corlanor | ivabradine | Amgen Inc | NDA | Current |
| 55513-813 | Corlanor | ivabradine | Amgen Inc | NDA | Current |
| 55513-813 | Corlanor | ivabradine | Amgen Inc | NDA | Current |
| 55513-813 | Corlanor | ivabradine | Amgen Inc | NDA | Current |
| 55513-813 | Corlanor | ivabradine | Amgen Inc | NDA | Current |
| 55513-813 | Corlanor | ivabradine | Amgen Inc | NDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 68406 | SUPPL | 2021-08-18 |
| 68309 | SUPPL | 2021-08-06 |
| 68299 | SUPPL | 2021-08-05 |
| 60827 | ORIG | 2019-11-13 |
| 58373 | ORIG | 2019-04-24 |
| 58363 | ORIG | 2019-04-22 |
| 58362 | ORIG | 2019-04-22 |
| 63083 | ORIG | 1900-01-01 |
| 63082 | ORIG | 1900-01-01 |
| 63081 | ORIG | 1900-01-01 |